Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$28.29 - $39.89 $596,919 - $841,679
-21,100 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$24.45 - $31.59 $132,030 - $170,586
5,400 Added 34.39%
21,100 $606,000
Q3 2020

Nov 13, 2020

SELL
$17.22 - $24.59 $1.1 Million - $1.57 Million
-63,900 Reduced 80.28%
15,700 $383,000
Q2 2020

Aug 13, 2020

BUY
$6.46 - $19.27 $514,216 - $1.53 Million
79,600 New
79,600 $1.42 Million

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.